ClinicalTrials.govpublic full text
Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14
adhd, adhd, methylphenidate hydrochloride, modified-release, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 899404
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.